Evidence map›Paper›PMID 31248918›Full record

Trial reportBMJ open2019

The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study.

Marta Seretny, Sarah Rose Murray, Lucy Whitaker, Jonathan Murnane, Heather Whalley, Cyril Pernet, Andrew W Horne

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The Effect of Neuromodulatory Drugs on the Intensity of Chronic Pelvic Pain in Women: A Systematic Review.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta SeretnyEdinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK.
Sarah Rose MurrayMRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
Lucy WhitakerMRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
Jonathan MurnaneQueens Medical Research Institute and Edinburgh Imaging Facility (QMRI), University of Edinburgh, Edinburgh, UK.
Heather WhalleyCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Cyril PernetQueens Medical Research Institute and Edinburgh Imaging Facility (QMRI), University of Edinburgh, Edinburgh, UK.
Andrew W HorneMRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.

Funding

Chief Scientist Office CZH/4/688Chief Scientist Office PCL/19/01Department of Health EME/13/52/04Medical Research Council MR/N022556/1Wellcome Trust
6 · The paper itself

Abstract

objectiveTo inform feasibility and design of a future randomised controlled trial (RCT) using brain functional MRI (fMRI) to determine the mechanism of action of gabapentin in managing chronic pelvic pain (CPP) in women.

designMechanistic study embedded in pilot RCT.

settingUniversity Hospital.

participantsTwelve women (18-50 years) with CPP and no pelvic pathology (follow-up completed March 2014).

interventionOral gabapentin (300-2700 mg) or matched placebo. OUTCOME MEASURES: After 12 weeks of treatment, participants underwent fMRI of the brain (Verio Siemens 3T MRI) during which noxious heat and punctate stimuli were delivered to the pelvis and arm. Outcome measures included pain (visual analogue scale), blood oxygen level dependent signal change and a semi-structured acceptability questionnaire at study completion prior to unblinding.

resultsFull datasets were obtained for 11 participants. Following noxious heat to the abdomen, the gabapentin group (GG) had lower pain scores (Mean: 3.8 [SD 2.2]) than the placebo group (PG) (Mean: 5.8 [SD 0.9]). This was also the case for noxious heat to the arm with the GG having lower pain scores (Mean: 2.6 [SD 2.5]) than the PG (Mean: 6.2 [SD 1.1]). Seven out of 12 participants completed the acceptability questionnaire. 71% (five out of seven) described their participation in the fMRI study as positive; the remaining two rated it as a negative experience.

conclusionsIncorporating brain fMRI in a future RCT to determine the mechanism of action of gabapentin in managing CPP in women was feasible and acceptable to most women. TRIAL REGISTRATION NUMBER: ISRCTN70960777.

Indexed as

AdolescentAdultAnalgesicsBrainBrain MappingChronic PainFemaleGabapentinHumansMagnetic Resonance ImagingMiddle AgedPain MeasurementPelvic PainPilot ProjectsSurveys and QuestionnairesYoung AdultAnalgesicsGabapentinchronic pelvic painfunctional magnetic resonance imaging (fMRI)Gabapentinpilot randomised control trial (RCT)pilot studyplacebo

Identifiers

PMID31248918
PMCPMC6597644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.